Article
Interaction between PNPLA3 I148M variant and age at infection in determining fibrosis progression in chronic hepatitis C.
PloS one - 1 Jan 2014
De Nicola Stella, Dongiovanni Paola, Aghemo Alessio, Cheroni Cristina, D'Ambrosio Roberta, Pedrazzini Michele, Marabita Francesco, Donnici Lorena, Maggioni Marco, Fargion Silvia, Colombo Massimo, De Francesco Raffaele, Valenti Luca
Abstract excerpt
BACKGROUND AND AIMS: The PNPLA3 I148M sequence variant favors hepatic lipid accumulation and confers susceptibility to hepatic fibrosis and hepatocellular carcinoma. The aim of this study was to estimate the effect size of homozygosity for the PNPLA3 I148M variant (148M/M) on the fibrosis progression rate (FPR) and the interaction with age at infection in chronic hepatitis C (CHC). METHODS: FPR was estimated in a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
